• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    SC Pharmaceuticals Inc (NQ: SCPH )

    4.384 -0.146 (-3.21%)
    Streaming Delayed Price Updated: 11:06 AM EDT, Oct 21, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 44,538
    Open 4.510
    Bid (Size) 4.380 (9)
    Ask (Size) 4.400 (9)
    Prev. Close 4.530
    Today's Range 4.384 - 4.580
    52wk Range 3.240 - 6.710
    Shares Outstanding 35,769,073
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    SCPH Stock Earnings: scPharmaceuticals Misses EPS, Misses Revenue for Q2 2024
    SCPH stock results show that scPharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Heart Failure-Focused scPharmaceuticals Secures FDA Approval For Expanded Use Of Furoscix, Receives Funding To Expand Commercialization
    FDA approves scPharmaceuticals' expanded Furoscix indication to include NYHA Class IV heart failure patients. scPharmaceuticals secures $125M non-dilutive financing to repay debt and advance... 
    Via Benzinga
    Exposures Product Safety

    Performance

    YTD
    -31.39%
    -31.39%
    1 Month
    -15.36%
    -15.36%
    3 Month
    -6.12%
    -6.12%
    6 Month
    -4.06%
    -4.06%
    1 Year
    -19.99%
    -19.99%

    More News

    Read More
    7 Short-Squeeze Stocks That Could Beat Down the Bears
    Via InvestorPlace
    SCPH Stock Earnings: scPharmaceuticals Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Recap: scPharmaceuticals Q4 Earnings
    Via Benzinga
    A Preview Of scPharmaceuticals's Earnings
    Via Benzinga
    Recap: scPharmaceuticals Q3 Earnings
    Via Benzinga
    Earnings Preview: scPharmaceuticals
    Via Benzinga
    Earnings Scheduled For March 13, 2024
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Earnings Outlook For scPharmaceuticals
    Via Benzinga
    The Latest Analyst Ratings for scPharmaceuticals
    Via Benzinga
    Analyst Ratings for scPharmaceuticals
    Via Benzinga
    Earnings Outlook For scPharmaceuticals
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
    Via Benzinga
    Dow Up 150 Points; Gold Jumps Over 2%
    Via Benzinga
    Earnings Preview For scPharmaceuticals
    Via Benzinga
    Earnings Scheduled For August 10, 2023
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Nasdaq Surges Over 2%; Accenture To Reduce 19,000 Jobs
    Via Benzinga
    KB Home, Accenture, Netflix And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.